HEATHER PREVIS: Open Payments
NPI 1477000370 · STRATFORD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,789 in 135 payments from 27 companies in 2025. Trend: 2023 $2,997 · 2024 $2,937 · 2025 $2,789
Food & beverage: $2,789
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 22 | $475 |
| GlaxoSmithKline, LLC. | 16 | $320 |
| Astellas Pharma US Inc | 9 | $267 |
| Novo Nordisk Inc | 13 | $258 |
| Exact Sciences Corporation | 9 | $180 |
| Lilly USA, LLC | 9 | $156 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $141 |
| ABBVIE INC. | 6 | $134 |
| ANI Pharmaceuticals, Inc. | 5 | $126 |
| Viatris Specialty LLC | 5 | $90 |
Products named: FARXIGA, Veozah, TRELEGY ELLIPTA, BREZTRI, XIFAXAN, PURIFIED CORTROPHIN GEL, VRAYLAR, JARDIANCE.
Industry payments across CT — which companies pay providers there.
